A detailed history of Swedbank Ab transactions in Exact Sciences Corp stock. As of the latest transaction made, Swedbank Ab holds 17,515 shares of EXAS stock, worth $867,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,515
Previous 17,515 -0.0%
Holding current value
$867,693
Previous $740,000 61.08%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$41.33 - $74.26 $903,060 - $1.62 Million
-21,850 Reduced 55.51%
17,515 $740,000
Q1 2024

May 21, 2024

BUY
$56.27 - $73.77 $2.22 Million - $2.9 Million
39,365 New
39,365 $2.72 Billion

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.77B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.